-
1
-
-
34548690793
-
Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis
-
Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 2007; 110: 2331-3
-
(2007)
Blood
, vol.110
, pp. 2331-2333
-
-
Akin, C.1
Scott, L.M.2
Kocabas, C.N.3
Kushnir-Sukhov, N.4
Brittain, E.5
Noel, P.6
Metcalfe, D.D.7
-
2
-
-
1642541866
-
Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: An in vivo microdialysis study in human skin
-
Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 2004; 98:364-70
-
(2004)
Anesth Analg
, vol.98
, pp. 364-370
-
-
Blunk, J.A.1
Schmelz, M.2
Zeck, S.3
Skov, P.4
Likar, R.5
Koppert, W.6
-
4
-
-
33745684645
-
Schweregradmarker der systemischen Masto- zytose.
-
Brockow K. Schweregradmarker der systemischen Masto- zytose. Allergo J 2006; 15:273-9
-
(2006)
Allergo J
, vol.15
, pp. 273-279
-
-
Brockow, K.1
-
5
-
-
0037380382
-
Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology
-
Brockow K, Akin C, Huber M, Metcalfe DD. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003; 48:508-16
-
(2003)
J Am Acad Dermatol
, vol.48
, pp. 508-516
-
-
Brockow, K.1
Akin, C.2
Huber, M.3
Metcalfe, D.D.4
-
6
-
-
18044387400
-
Diagnostischer Wert von Mastzellmediatoren bei der Anaphylaxie.
-
Brockow K, Behrendt H, Ring J. Diagnostischer Wert von Mastzellmediatoren bei der Anaphylaxie. Allergologie 2005; 28:125-9
-
(2005)
Allergologie
, vol.28
, pp. 125-129
-
-
Brockow, K.1
Behrendt, H.2
Ring, J.3
-
7
-
-
37749039528
-
Anaphylaxis in patients with mastocytosis - a study on history, clinical features and risk factors in 120 patients
-
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis - a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-32
-
(2008)
Allergy
, vol.63
, pp. 226-232
-
-
Brockow, K.1
Jofer, C.2
Behrendt, H.3
Ring, J.4
-
8
-
-
33645721635
-
Mastozytose - Ursache anaphylaktoider Reaktionen
-
Brockow K, Ring J. Mastozytose - Ursache anaphylaktoider Reaktionen. Allergo J 2006; 15:143-52
-
(2006)
Allergo J
, vol.15
, pp. 143-152
-
-
Brockow, K.1
Ring, J.2
-
9
-
-
34447335096
-
Flushing and increase of serum tryptase after mechanical irritation of a solitary mastocytoma
-
Bussmann C, Hagemann T, Hanfland J, Haidl C, Bieber T, Novak N. Flushing and increase of serum tryptase after mechanical irritation of a solitary mastocytoma. Eur J Dermatol 2007; 17:332-4
-
(2007)
Eur J Dermatol
, vol.17
, pp. 332-334
-
-
Bussmann, C.1
Hagemann, T.2
Hanfland, J.3
Haidl, C.4
Bieber, T.5
Novak, N.6
-
10
-
-
34249787870
-
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis
-
Carter MC, Robyn JA, Bressler PB, Walker JC, Shapiro GG, Metcalfe DD. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J Allergy Clin Immunol 2007;119:1550-1
-
(2007)
J Allergy Clin Immunol
, vol.119
, pp. 1550-1551
-
-
Carter, M.C.1
Robyn, J.A.2
Bressler, P.B.3
Walker, J.C.4
Shapiro, G.G.5
Metcalfe, D.D.6
-
11
-
-
20144389124
-
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
-
Florian S, Krauth MT, Simonitsch-Klupp I, Sperr WR, Fritsche-Polanz R, Sonneck K, Födinger M, Agis H, Böhm A, Wimazal F, Horny HP, Valent P. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005; 136:273-80
-
(2005)
Int Arch Allergy Immunol
, vol.136
, pp. 273-280
-
-
Florian, S.1
Krauth, M.T.2
Simonitsch-Klupp, I.3
Sperr, W.R.4
Fritsche-Polanz, R.5
Sonneck, K.6
Födinger, M.7
Agis, H.8
Böhm, A.9
Wimazal, F.10
Horny, H.P.11
Valent, P.12
-
12
-
-
0030746118
-
Hymenoptera sting anaphylaxis and urticaria pigmentosa: Clinical findings and results of venom immunotherapy in ten patients
-
Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997; 100:11-5
-
(1997)
J Allergy Clin Immunol
, vol.100
, pp. 11-15
-
-
Fricker, M.1
Helbling, A.2
Schwartz, L.3
Muller, U.4
-
13
-
-
0030467664
-
Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue
-
Genovese A, Stellato C, Patella V, Lamparter-Schummert B, de Crescenzo G, Adt M, Marone G. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Int J Clin Lab Res 1996; 26:192-8
-
(1996)
Int J Clin Lab Res
, vol.26
, pp. 192-198
-
-
Genovese, A.1
Stellato, C.2
Patella, V.3
Lamparter-Schummert, B.4
de Crescenzo, G.5
Adt, M.6
Marone, G.7
-
14
-
-
34648816795
-
Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA)
-
González de Olano D, de la Hoz Caballer B, Núñez López R, Sánchez Muñoz L, Cuevas Agustín M, Diéguez MC, Alvarez Twose I, Castells MC, Escribano Mora L. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007; 37:1547-55
-
(2007)
Clin Exp Allergy
, vol.37
, pp. 1547-1555
-
-
González de Olano, D.1
de la Hoz Caballer, B.2
Núñez López, R.3
Sánchez Muñoz, L.4
Cuevas Agustín, M.5
Diéguez, M.C.6
Alvarez Twose, I.7
Castells, M.C.8
Escribano Mora, L.9
-
15
-
-
1542286592
-
Incidence of anaphylaxis with circulatory symptoms: A study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern
-
Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285-90
-
(2004)
Clin Exp Allergy
, vol.34
, pp. 285-290
-
-
Helbling, A.1
Hurni, T.2
Mueller, U.R.3
Pichler, W.J.4
-
16
-
-
2342591290
-
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
-
Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BO, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 832-836
-
-
Johansson, S.G.1
Bieber, T.2
Dahl, R.3
Friedmann, P.S.4
Lanier, B.O.5
Lockey, R.F.6
Motala, C.7
Ortega Martell, J.A.8
Platts-Mills, T.A.9
Ring, J.10
Thien, F.11
Van Cauwenberge, P.12
Williams, H.C.13
-
18
-
-
0035798947
-
Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings
-
Ludolph-Hauser D, Ruëff F, Fries C, Schöpf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357:361-2
-
(2001)
Lancet
, vol.357
, pp. 361-362
-
-
Ludolph-Hauser, D.1
Ruëff, F.2
Fries, C.3
Schöpf, P.4
Przybilla, B.5
-
19
-
-
0027222696
-
Mechanisms of activation of human mast cells and basophils by general anesthetic drugs
-
Marone G, Stellato C, Mastronardi P, Mazzarella B. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Ann Fr Anesth Reanim 1993; 12:116-25
-
(1993)
Ann Fr Anesth Reanim
, vol.12
, pp. 116-125
-
-
Marone, G.1
Stellato, C.2
Mastronardi, P.3
Mazzarella, B.4
-
20
-
-
0029885616
-
Acetylsalicylsäure als Augmentationsfaktor einer Nahrungsmittel-Allergie.
-
Moller R, Paul E. Acetylsalicylsäure als Augmentationsfaktor einer Nahrungsmittel-Allergie. Hautarzt 1996; 47: 281-3
-
(1996)
Hautarzt
, vol.47
, pp. 281-283
-
-
Moller, R.1
Paul, E.2
-
21
-
-
34250024319
-
Recent advances in the understanding of mastocytosis: The role of KIT mutations
-
Orfao A, Garcia-Montero AC, Sanchez L, Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007; 138:12-30
-
(2007)
Br J Haematol
, vol.138
, pp. 12-30
-
-
Orfao, A.1
Garcia-Montero, A.C.2
Sanchez, L.3
Escribano, L.4
-
22
-
-
0031016905
-
-
Related Articles, LinksOude Elberink JN, de Monchy JG, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 1997; 99:153-4
-
Related Articles, LinksOude Elberink JN, de Monchy JG, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 1997; 99:153-4
-
-
-
-
23
-
-
8344273609
-
Erhöhte basale Ser umtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie.
-
Przybilla B, Müller U, Jarisch R, Rueff F. Erhöhte basale Ser umtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie. Allergo J 2004; 13: 440-2
-
(2004)
Allergo J
, vol.13
, pp. 440-442
-
-
Przybilla, B.1
Müller, U.2
Jarisch, R.3
Rueff, F.4
-
24
-
-
33749453162
-
Fatal outcome of a Vespula sting in a patient with mastocytosis after specific immunotherapy with honey bee venom
-
Reimers A, Müller U. Fatal outcome of a Vespula sting in a patient with mastocytosis after specific immunotherapy with honey bee venom. Allergy Clin Immunol Int 2005; 17 (Suppl 1): 69-70
-
(2005)
Allergy Clin Immunol Int
, vol.17
, Issue.SUPPL. 1
, pp. 69-70
-
-
Reimers, A.1
Müller, U.2
-
25
-
-
64849090465
-
Recurrent severe anaphylactic reactions to venom immunotherapy (VIT): Omalizumab induces tolerance
-
Rerinck HC, Rueff F, Przybilla B. Recurrent severe anaphylactic reactions to venom immunotherapy (VIT): omalizumab induces tolerance. J Allergy Clin Immunol 2008; 121 (Suppl 1): S29
-
(2008)
J Allergy Clin Immunol
, vol.121
, Issue.SUPPL. 1
-
-
Rerinck, H.C.1
Rueff, F.2
Przybilla, B.3
-
27
-
-
35349018009
-
Akuttherapie anaphylaktischer Reaktionen.
-
Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs T, Huttegger I, Kapp A, Klimek L, Müller U, Niggemann B, Pfaar O, Przybilla B, Rebien W, Rietschel E, Ruëff F, Schnadt S, Tryba M, Worm M, Sitter H, Schultze-Werninghaus C. Akuttherapie anaphylaktischer Reaktionen. Allergo J 2007; 16:420-34
-
(2007)
Allergo J
, vol.16
, pp. 420-434
-
-
Ring, J.1
Brockow, K.2
Duda, D.3
Eschenhagen, T.4
Fuchs, T.5
Huttegger, I.6
Kapp, A.7
Klimek, L.8
Müller, U.9
Niggemann, B.10
Pfaar, O.11
Przybilla, B.12
Rebien, W.13
Rietschel, E.14
Ruëff, F.15
Schnadt, S.16
Tryba, M.17
Worm, M.18
Sitter, H.19
Schultze-Werninghaus, C.20
more..
-
28
-
-
0017329005
-
Incidence and severity of anaphylactoid reactions to colloid volume substitutes
-
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1:466-9
-
(1977)
Lancet
, vol.1
, pp. 466-469
-
-
Ring, J.1
Messmer, K.2
-
30
-
-
0020018119
-
Shock syndrome associated with mastocytosis: Pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks
-
Roberts LJ 2nd, Turk JW, Oates JA. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Res 1982; 8:145-52
-
(1982)
Adv Shock Res
, vol.8
, pp. 145-152
-
-
Roberts 2nd, L.J.1
Turk, J.W.2
Oates, J.A.3
-
31
-
-
30344455110
-
Diagnose und Therapie der Insektengiftallergie bei Mastozytose.
-
Rueff F, Dugas-Breit S, Bauer C, Schöpf P, Albert K, Marx R, Przybilla B. Diagnose und Therapie der Insektengiftallergie bei Mastozytose. Allergo J 2005; 14: 514-5
-
(2005)
Allergo J
, vol.14
, pp. 514-515
-
-
Rueff, F.1
Dugas-Breit, S.2
Bauer, C.3
Schöpf, P.4
Albert, K.5
Marx, R.6
Przybilla, B.7
-
33
-
-
64849097978
-
Mastozytose: Ein Risikofaktor für Anaphylaxie?
-
Rueff F, Schöpf P, Przybilla B. Mastozytose: ein Risikofaktor für Anaphylaxie? Allergo J 2007; 16:40
-
(2007)
Allergo J
, vol.16
, pp. 40
-
-
Rueff, F.1
Schöpf, P.2
Przybilla, B.3
-
34
-
-
0035216249
-
Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses
-
Rueff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 2001; 108:1027-32
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 1027-1032
-
-
Rueff, F.1
Wenderoth, A.2
Przybilla, B.3
-
35
-
-
0023262466
-
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
-
Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316:1622-6
-
(1987)
N Engl J Med
, vol.316
, pp. 1622-1626
-
-
Schwartz, L.B.1
Metcalfe, D.D.2
Miller, J.S.3
Earl, H.4
Sullivan, T.5
-
36
-
-
33846230873
-
Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome
-
Sonneck K, Florian S, Müllauer L, Wimazal F, Födinger M, Sperr WR, Valent P. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 2007; 142:158-64
-
(2007)
Int Arch Allergy Immunol
, vol.142
, pp. 158-164
-
-
Sonneck, K.1
Florian, S.2
Müllauer, L.3
Wimazal, F.4
Födinger, M.5
Sperr, W.R.6
Valent, P.7
-
37
-
-
34249333084
-
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
-
Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine 0, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37:435-53
-
(2007)
Eur J Clin Invest
, vol.37
, pp. 435-453
-
-
Valent, P.1
Akin, C.2
Escribano, L.3
Födinger, M.4
Hartmann, K.5
Brockow, K.6
Castells, M.7
Sperr, W.R.8
Kluin-Nelemans, H.C.9
Hamdy, N.A.10
Lortholary, O.11
Robyn, J.12
van Doormaal, J.13
Sotlar, K.14
Hauswirth, A.W.15
Arock, M.16
Hermine 017
Hellmann, A.18
Triggiani, M.19
Niedoszytko, M.20
Schwartz, L.B.21
Orfao, A.22
Horny, H.P.23
Metcalfe, D.D.24
more..
-
38
-
-
23844490453
-
Mastocytosis and adverse reactions to biogenic amines and histamine- releasing foods: What is the evidence?
-
Vlieg-Boerstra BJ, van der Heide S, Oude Elberink JN, Kluin-Nelemans JC, Dubois AE. Mastocytosis and adverse reactions to biogenic amines and histamine- releasing foods: what is the evidence? Neth J Med 2005; 63: 244-9
-
(2005)
Neth J Med
, vol.63
, pp. 244-249
-
-
Vlieg-Boerstra, B.J.1
van der Heide, S.2
Oude Elberink, J.N.3
Kluin-Nelemans, J.C.4
Dubois, A.E.5
-
39
-
-
40549132386
-
Fatal anaphylactic sting reaction in a patient with mastocytosis
-
Wagner N, Fritze D, Przybilla B, Hagedorn M, Rueff F. Fatal anaphylactic sting reaction in a patient with mastocytosis. Int Arch Allergy Clin Immunol 2008; 146:162-3
-
(2008)
Int Arch Allergy Clin Immunol
, vol.146
, pp. 162-163
-
-
Wagner, N.1
Fritze, D.2
Przybilla, B.3
Hagedorn, M.4
Rueff, F.5
-
40
-
-
40549127931
-
Omalizumab ermöglicht Einleitung einer Hyposensibilisierungsbehandlung mit Bienengift bei Risikopatient mit erhöhter Serumtryptase.
-
Wieczorek D, Kapp A, Wedi B. Omalizumab ermöglicht Einleitung einer Hyposensibilisierungsbehandlung mit Bienengift bei Risikopatient mit erhöhter Serumtryptase. Allergo J 2005; 14:515
-
(2005)
Allergo J
, vol.14
, pp. 515
-
-
Wieczorek, D.1
Kapp, A.2
Wedi, B.3
|